SCHOTT Pharma is reinforcing its commitment to reduce GHG emissions in alignment with climate science and the goal to limit global warming to 1.5 degrees Celsius. The climate action roadmap of the SCHOTT Group was validated by the Science Based Targets initiative (SBTi). Recognizing the criticality of climate change, SCHOTT Pharma is dedicated to taking responsibility for its business operations’ impact and contributing to global decarbonization efforts.
“The time to act on climate change is now. We must all take responsibility – governments, society, and companies,” said Dr. Almuth Steinkühler, CFO of SCHOTT Pharma. “At SCHOTT Pharma, it’s our priority to drive solutions for a more sustainable future. In particular, we are focusing on decarbonization through various initiatives ranging from green electricity use to low-emission manufacturing technology, ecodesign and circular economy.”
Committed to science-based targets
As research-focused companies, SCHOTT and SCHOTT Pharma share the ambition to align activities and targets with current climate science. Therefore, the climate action roadmap was reviewed with the independent Science Based Targets initiative in 2023, which validated quantitative targets for the entire group. Explicitly, the targets include an absolute reduction of 46.2 percent in Scope 1 and Scope 2 GHG emissions by 2030.
The validated targets also guide Scope 3 reduction activities, with a commitment to reduce 27.5 percent of Scope 3 GHG emissions related to fuel and energy-related activities (Scope 3.3) and its investments (Scope 3.15) by 2030, as well as a commitment to engage its supply chain to source 74.23 percent of purchased goods and services (Scope 3.1), capital goods (Scope 3.2) and upstream transport and distribution (Scope 3.4) from suppliers with their own science-based target commitments by 2027.
As per guidance of SBTi on Organizational Boundary, the target validation process was executed at the parent- or group level rather than for SCHOTT Pharma alone. Thus, SCHOTT Pharma is committed to fulfilling its share to these same targets within the scope of its business activities and to reporting its progress transparently.
More information about SCHOTT Pharma’s climate targets.